Fibrinogen–Albumin Ratio Index (FARI) as a Certain Prognostic Biomarker in Pretreated Patients with Immunotherapy

References

• Mantovani A , Allavena P , Sica A , et al. Cancer-related inflammation. Nature . 2008;454:436–444. doi:10.1038/nature07205 18650914
   PubMed Web of Science ®Google Scholar
• Beer TM , Armstrong AJ , Rathkopf DE , et al. Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med . 2014;371(5):424–433. doi:10.1056/NEJMoa1405095 24881730
   PubMed Web of Science ®Google Scholar
• Ryan CJ , Smith MR , Fizazi K , et al. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled Phase 3 study. Lancet Oncol . 2015;16(2):152–160. doi:10.1016/S1470-2045(14)71205-7 25601341
   PubMed Web of Science ®Google Scholar
• Zou W . Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer . 2005;5(4):263–274. doi:10.1038/nrc1586 15776005
   PubMed Web of Science ®Google Scholar
• Dolan RD , McSorley ST , Park JH , et al. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores. Br J Cancer . 2018;119(1):40–51. doi:10.1038/s41416-018-0095-9 29789606
   PubMed Web of Science ®Google Scholar
• Hu B , Yang XR , Xu Y , et al. Systemic immune–inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res . 2014;20(23):6212–6222. doi:10.1158/1078-0432.CCR-14-0442 25271081
   PubMed Web of Science ®Google Scholar
• Jagadesham VP , Lagarde SM , Immanuel A , et al. Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction. Br J Surg . 2017;104(4):401–407. doi:10.1002/bjs.10425 28072456
   PubMed Web of Science ®Google Scholar
• Zhu ML , Feng M , He F , et al. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical cancer. Clinica Chimica Acta . 2018;483:296–302. doi:10.1016/j.cca.2018.05.025
   PubMed Web of Science ®Google Scholar
• Cruz-Ramos M , Puerto-Nevado LD , Zheng BB , et al. Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer. J Geratic Oncol . 2019;10(5):742–748. doi:10.1016/j.jgo.2018.10.002
   PubMed Web of Science ®Google Scholar
• Wu YC , Li C , Zhao J , et al. Neutrophil-to-lymphocyte and platelet-tolymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis. World J Surg Oncol . 2016;14(1):289. doi:10.1186/s12957-016-1044-9 27852294
   PubMed Web of Science ®Google Scholar
• Kang MH , Go S-I , Song H-N , et al. The prognostic impact of the neutrophil-tolymphocyte ratio in patients with small-cell lung cancer. Br J Cancer . 2014;111(3):452–460. doi:10.1038/bjc.2014.317 24921916
   PubMed Web of Science ®Google Scholar
• Deng Q , He B , Liu X , et al. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. J Transl Med . 2015;13:66. doi:10.1186/s12967-015-0409-0 25885254
   PubMed Web of Science ®Google Scholar
• Giakoustidis A , Neofytou K , Neves MC , et al. Identifying the role of neutrophil-to-lymphocyte radio and platelets-to-lymphocyte radio as prognostic markers in patients undergoing resection of pancreatic ductal adenocarcinoma. Ann Hepatobiliary Pancreat Surg . 2018;22(3):197–207. doi:10.14701/ahbps.2018.22.3.197 30215041
   PubMedGoogle Scholar
• Bagley SJ , Kothari S , Aggarwal C , et al. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Lung Cancer . 2017;106:1–7. doi:10.1016/j.lungcan.2017.01.013 28285682
   PubMed Web of Science ®Google Scholar
• Diem S , Schmid S , Krapf M , et al. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio(PLR) as prognostic markers in patients with non-small cell lung cancer(NSCLC) treated with nivolumab. Lung Cancer . 2017;111:176–181. doi:10.1016/j.lungcan.2017.07.024 28838390
   PubMed Web of Science ®Google Scholar
• Templeton AJ , Pezaro C , Omlin A , et al. Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio. Cancer . 2014;120(21):3346–3352. doi:10.1002/cncr.28890 24995769
   PubMed Web of Science ®Google Scholar
• Templeton AJ , Ace O , McNamara MJ , et al. Prognostic role of platelet to lymphocyte radio in solid tumors: a systematic review and meta-analysis. Cancer Epidemoil Biomarkers Prev . 2014;23(7):1204–1212. doi:10.1158/1055-9965.EPI-14-0146
   PubMed Web of Science ®Google Scholar
• Ettinger DS , Aisner DL , Wood DE , et al. NCCN guidelines insights: non-small cell lung cancer, version 5. 2018. J Natl Compr Cancer Netw . 2018;16(7):807–821. doi:10.6004/jnccn.2018.0062
   PubMed Web of Science ®Google Scholar
• Gandara DR , Paul SM , Kowanetz M , et al. Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atizolizumab. Nat Med . 2018;24(9):1441–1448. doi:10.1038/s41591-018-0134-3 30082870
   PubMed Web of Science ®Google Scholar
• Hellamnn MD , Ciuleanu TE , Pluzanski A , et al. Nivolumab plus Ipimumab in lung cancer with a high tumor mutational burden. N Engl J Med . 2018;378(22):2093–2104. doi:10.1056/NEJMoa1801946 29658845
   PubMed Web of Science ®Google Scholar
• Cai W , Kong W , Dong B , et al. Pretreatment serum prealbumin as an independent prognostic indicator in patients with metastatic renal cell carcinoma using tyosine kinase inhibitors as first-line target therapy. Clin Genitourin Cancer . 2017;15(3):437–446. doi:10.1016/j.clgc.2017.01.008
   Web of Science ®Google Scholar
• Kawai H , Ota H . Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resction for non-small-cell lung cancer. World J Surg . 2012;36(12):2853–2857. doi:10.1007/s00268-012-1766-y 22948197
   PubMed Web of Science ®Google Scholar
• Kelly P , Paulin F , Lamont D , et al. Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer. Br J Cancer . 2012;106(5):955–961. doi:10.1038/bjc.2012.15 22294182
   PubMed Web of Science ®Google Scholar
• Gao QF , Qia JC , Huang XH , et al. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy. Cancer Cell Int . 2018;18:153. doi:10.1186/s12935-018-0648-2 30305803
   PubMed Web of Science ®Google Scholar
• Xu WY , Zhang HH , Xiong JP , et al. Prognositic significance of the fibrinogen-to-albumin ratio in gallbladder cancer patients. World J Gastroenterol . 2018;24(29):3281–3292. doi:10.3748/wjg.v24.i29.3281 30090008
   PubMed Web of Science ®Google Scholar
• Kalemkerian GP , Loo BW , Akerley W , et al. NCCN guidelines insights: small cell lung cancer, version 2. 2018. J Natl Compr Cancer Netw . 2018;16:1171–1182. doi:10.6004/jnccn.2018.0079
   PubMed Web of Science ®Google Scholar
• Von Mehren M , Randall RL , Benjamin RS , et al. Soft tissue sarcoma, version 2.2018, NCCN clinical practive guidelines in oncology. J Natl Compr Cancer Netw . 2018;16(5):536–563. doi:10.6004/jnccn.2018.0025
   PubMed Web of Science ®Google Scholar
• Qiu H , Zhou Z . Updates and interpretation on NCCN clinical practice guidelines for gastric cancer 2017 version 5. Zhonghua Wei Chang Wai Ke Za Zhi . 2018;21(2):160–164.29492914
   PubMedGoogle Scholar
• Provenzale D , Gupta S , Ahnen DJ , et al. NCCN guidelines insights: colorectal cancer screeing, version 1.2018. Natl Compr Cancer Netw . 2018;16(8):939–949. doi:10.6004/jnccn.2018.0067
   PubMed Web of Science ®Google Scholar
• Covey AM . Hepatocellular carcinoma: updates to screeing and diagonsis. J Natl Compr Cancer Netw . 2018;16(5S):633–665.
   Google Scholar
• Li SQ , Jiang YH , Lin J , et al. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals. Cancer Med . 2018;7(4):1221–1231. doi:10.1002/cam4.1428 29533009
   PubMed Web of Science ®Google Scholar
• Man YN , Chen YF . Systemic immune-inflammation index, serum albumin, and fibrinogen impact prognosis in castration-resistant prostate cancer patients treated with first-line docetaxel. Int Urol Nephrol . 2019;51(12):2189–2199. doi:10.1007/s11255-019-02265-4 31456101
   PubMed Web of Science ®Google Scholar
• Wang YY , Liu ZZ , Xu D , et al. Fibrinogen-Albumin Ratio Index (FARI): a more promising inflammation-based pronostic marker for patients undergoing hepatectomy for colorectal liver metastases. Ann Surg Oncol . 2019;26(11):3682–3692. doi:10.1245/s10434-019-07586-3 31264117
   PubMed Web of Science ®Google Scholar
• You XY , Zhou Q , Song J , et al. Preoperative albumin-to-fibrinogen ratio predicts severe postoperative complications in elderly gastric cancer subjects after radical laparoscopic gastrectomy. BMC Cancer . 2019;19(1):931. doi:10.1186/s12885-019-6143-x 31533682
   PubMed Web of Science ®Google Scholar